title: Guidelines for cardiovascular risk assessment and cholesterol treatment--reply.
authors.affiliation: Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota.
authors.forename: Victor M
authors.initials: VM
authors.lastname: Montori
authors.affiliation: Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota.
authors.forename: Juan P
authors.initials: JP
authors.lastname: Brito
authors.affiliation: Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota.
authors.forename: Henry H
authors.initials: HH
authors.lastname: Ting
mesh_terms: D002318:Cardiovascular Diseases / Q000517:prevention & control*; D008078:Cholesterol, LDL; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006937:Hypercholesterolemia / Q000188:drug therapy* / Q000517:prevention & control*; D008297:Male; D018802:Patient-Centered Care; D017410:Practice Guidelines as Topic
chemical_list: D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors